Announced Mon, 20 Jul · 17:33 IST
Board meeting on July 30, 2026 to approve Q1 FY27 results
Results View source PDF
MEDANTA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+1.0%1-day move
₹1340.00
prior close
₹1340.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.0+0.1+0.5+0.9+1.0+2.7+2.2+5.3+4.5—————
Up moveDown movePending
AI summary
Global Health Limited (Medanta) has informed BSE that its Board of Directors will meet on Thursday, July 30, 2026 to consider and approve the unaudited financial results for the first quarter ended June 30, 2026. The trading window for insiders is already closed from July 1, 2026 and will reopen 48 hours after results are declared.
Likely market impact
Routine advance notice; no financial details yet. Investors should watch for the Q1 results on July 30 for actual performance data.